Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

ClinicalTrials.gov ID: NCT00957996

Public ClinicalTrials.gov record NCT00957996. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 29, 2026, 9:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label, Randomized Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, open-label, randomized study of the antiviral activity, safety, and tolerability of intravenous Peramivir in hospitalized subjects with confirmed or suspected influenza infection.

Study identification

NCT ID: NCT00957996
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: BioCryst Pharmaceuticals; Industry
Enrollment: 234 participants

Conditions and interventions

Conditions

Interventions

Peramivir Drug

Drug

Eligibility (public fields only)

Age range: 6 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 2009 (Type not available)
Primary completion: Oct 2010 (Actual)
Completion: Aug 2011 (Actual)
Last update posted: Feb 12, 2015

2009 – 2011

United States locations

U.S. sites: 79
U.S. states: 35
U.S. cities: 79

Facility	City	State	ZIP	Site status
Not listed	Dothan	Alabama	—	—
Not listed	Mobile	Alabama	—	—
Not listed	Jonesboro	Arkansas	—	—
Not listed	Little Rock	Arkansas	—	—
Not listed	Fountain Valley	California	—	—
Not listed	Harbor City	California	—	—
Not listed	La Mesa	California	—	—
Not listed	Long Beach	California	—	—
Not listed	Los Angeles	California	—	—
Not listed	Modesto	California	—	—
Not listed	Oceanside	California	—	—
Not listed	Orange	California	—	—
Not listed	Palo Alto	California	—	—
Not listed	Sacramento	California	—	—
Not listed	San Diego	California	—	—
Not listed	San Francisco	California	—	—
Not listed	San Jose	California	—	—
Not listed	Denver	Colorado	—	—
Not listed	Wheat Ridge	Colorado	—	—
Not listed	Washington D.C.	District of Columbia	—	—
Not listed	Brandon	Florida	—	—
Not listed	Fort Lauderdale	Florida	—	—
Not listed	Gainsville	Florida	—	—
Not listed	Ocoee	Florida	—	—
Not listed	Orlando	Florida	—	—
Not listed	West Palm Beach	Florida	—	—
Not listed	Columbus	Georgia	—	—
Not listed	Decatur	Georgia	—	—
Not listed	Honolulu	Hawaii	—	—
Not listed	Idaho Falls	Idaho	—	—
Not listed	Chicago	Illinois	—	—
Not listed	Rock Island	Illinois	—	—
Not listed	Springfield	Illinois	—	—
Not listed	Indianapolis	Indiana	—	—
Not listed	South Bend	Indiana	—	—
Not listed	Topeka	Kansas	—	—
Not listed	Hazard	Kentucky	—	—
Not listed	Natchitoches	Louisiana	—	—
Not listed	Shreveport	Louisiana	—	—
Not listed	Baltimore	Maryland	—	—
Not listed	Boston	Massachusetts	—	—
Not listed	Detroit	Michigan	—	—
Not listed	Royal Oak	Michigan	—	—
Not listed	Troy	Michigan	—	—
Not listed	Minneapolis	Minnesota	—	—
Not listed	St Louis	Missouri	—	—
Not listed	Butte	Montana	—	—
Not listed	Omaha	Nebraska	—	—
Not listed	Englewood	New Jersey	—	—
Not listed	Hackensack	New Jersey	—	—
Not listed	Neptune City	New Jersey	—	—
Not listed	New Brunswick	New Jersey	—	—
Not listed	Somers Point	New Jersey	—	—
Not listed	Albuquerque	New Mexico	—	—
Not listed	Albany	New York	—	—
Not listed	Brooklyn	New York	—	—
Not listed	Buffalo	New York	—	—
Not listed	Jamaica	New York	—	—
Not listed	New York	New York	—	—
Not listed	The Bronx	New York	—	—
Not listed	Valhalla	New York	—	—
Not listed	Akron	Ohio	—	—
Not listed	Cleveland	Ohio	—	—
Not listed	Lima	Ohio	—	—
Not listed	Toledo	Ohio	—	—
Not listed	Portland	Oregon	—	—
Not listed	Philadelphia	Pennsylvania	—	—
Not listed	Providence	Rhode Island	—	—
Not listed	Charleston	South Carolina	—	—
Not listed	Sioux Falls	South Dakota	—	—
Not listed	Houston	Texas	—	—
Not listed	San Antonio	Texas	—	—
Not listed	Tomball	Texas	—	—
Not listed	Salt Lake City	Utah	—	—
Not listed	Norfolk	Virginia	—	—
Not listed	Salem	Virginia	—	—
Not listed	Bellevue	Washington	—	—
Not listed	Seattle	Washington	—	—
Not listed	Milwaukee	Wisconsin	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00957996, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 12, 2015 · Synced Oct 29, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00957996 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →